|
|
|
Bristol Myers Squibb Co. | $2.00 Convertible Preferred Stock (BMYMP)
Prospectus excerpt: Bristol-Myers Squibb Co., $2.00 Convertible Preferred Stock, liquidation value $50 per share, callable any time at the company's option, and with no stated maturity. Distributions are paid quarterly on 3/1, 6/1, 9/1 & 12/1. Each preferred share is convertible any time at the holder's option into 16.96 common shares. Dividends paid by this preferred security are eligible for the preferential income tax rate of 15% to a maximum of 20% depending on the holder's tax bracket (and under IRS specified holding restrictions) and are also eligible for the dividends received deduction for corporate holders. , Secondary Prospectus PDF », BMY Page »
Redeemable?: | Yes | Call Date: | 4/28/2023 (Now Trading Post Call Date) | Perpetual?: | Yes | Cumulative?: | Yes | Conversion Ratio: | 16.96 | Liquidation Preference: | $50.00 | Original Coupon: | 4.00% | Pay Period: | Quarterly | Pay Dates: | 1-Mar, 1-Jun, 1-Sep, 1-Dec | CDx3 Compliance Rating: |
Learn BMYMP's Rating
|
|
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. Preferred: BMYMP Open the BMY Information Page »
|
Name: |
Bristol Myers Squibb Co. |
Website: |
www.bms.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding BMY: |
125 (see which ones) |
Total Market Value Held by ETFs: |
$11,707,500,876.91 |
Total Market Capitalization: |
$98,804,000,000 |
% of Market Cap. Held by ETFs: |
11.85% |
|
|
|
|
|